Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Among epidermal growth factor receptor (EGFR) mutation status unknown nonsmall cell lung cancer (NSCLC) patients, those with higher carcinoembryonic antigen (CEA) level are more likely to response to EGFR-tyrosine kinase inhibitors (TKIs) because they tend to have mutant epidermal growth factor rece...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Medicine (Baltimore)
Main Authors: Chen, Yu-Mu, Lai, Chien-Hao, Chang, Huang-Chih, Chao, Tung-Ying, Tseng, Chia-Cheng, Fang, Wen-Feng, Wang, Chin-Chou, Chung, Yu-Hsiu, Huang, Kuo-Tung, Chen, Hung-Cheng, Chang, Ya-Chun, Lin, Meng-Chih
Formato: Artigo
Idioma:Inglês
Publicado: Wolters Kluwer Health 2015
Assuntos:
5700
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5058911/
https://ncbi.nlm.nih.gov/pubmed/26683939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002239
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares